Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Jessie Bakker
Brigham and Women's Hospital, Department: Na
Should you be removed from our database? Contact us at [email protected]. Read more below.
Philips Respironics
Salary not from the awardee Institution
The research seeks to demonstrate the efficacy of a pharmacologic treatment as an alternative to CPAP for obstructive sleep apnea (OSA). Philips markets CPAP and BiPap therapy devices, masks, and other devices likely used in patients with obstructive sleep apnea (OSA). If successful, a portion of the OSA patient population will still require CPAP devices for therapy, but a subset of the OSA patient population would have an alternate therapy to CPAP providing competition to the company. Dr. Bakker' is employed by Philips Respironics.
A Novel Pharmacological Therapy for Obstructive Sleep Apnea
PROJECT NARRATIVE Obstructive sleep apnea is a serious health concern that is inadequately treated with existing therapies, and there is no pharmacological therapy available. The proposed research will advance knowledge through 1.) test- ing repeated-dose efficacy and tolerance of a highly-promising pharmacological therapy involving a combina- tion of agents to increase pharyngeal muscle responsiveness (~75% improvement in severity in preliminary da- ta), 2.) providing a better understanding of the mechanisms of action, and 3.) providing a means to identify pa- tients who may benefit most.
Filed on June 11, 2019.
Tell us what you know about Jessie Bakker's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Other search results for: “Jessie Bakker”
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Jessie Bakker | Brigham and Women's Hospital | Conflict of Interest | Philips Respironics | $150,000 - $199,999 |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.